Indonesia said yesterday it would probably strengthen anti-terrorism regulations to prevent attacks such as last week's bomb blast at a Jakarta hotel, as the US ambassador warned more attempts at attacks were likely. \nChief security minister Susilo Bambang Yudhoyono told reporters the Cabinet would debate the issue tomorrow, but added the world's most populous Muslim nation would not copy draconian security laws used by its neighbors. \nAnti-terrorism regulations were introduced in the wake of last October's Bali bombings that killed 202 people, mostly foreigners, but are not as far reaching as laws used in Singapore and Malaysia. \nAuthorities have blamed the Bali and hotel bombings as well as others over the past year on militant Muslims linked to the regional Jemaah Islamiah group and Osama bin Laden's al-Qaeda. \n"The main idea of the government is to revise the current law. Particularly, we will study whether the current regulation is accommodating enough or not," Yudhoyono told reporters. \nHowever, the government has "no thought" to "plagiarize the ISA [internal security acts] of Singapore and Malaysia." \n"The government is not as stupid as that, because our conditions are different, the substance is different," he said. \nThere have been calls by some officials for Indonesia to follow the Singapore and Malaysian examples of draconian internal security laws since the Aug. 5 bombing at the JW Marriott Hotel in Jakarta, which killed 12 people and wounded up to 150. \nBut civil rights groups and some legislators have responded angrily to suggestions the government might seek to revive laws similar to those used by former autocrat Suharto during his 32 years of iron rule that ended in 1998. \nUS envoy to Jakarta Ralph Boyce said he had warned Americans to expect more attempts at terror attacks. \nIn remarks to reporters who asked him about a meeting of US citizens in the heavily guarded embassy complex earlier, Boyce said a theme of his comments was that "we believe it likely there will be further attempts" by militants at such attacks. \nHe said he also suggested to those at the gathering that if they left the meeting more concerned or even more frightened than when they came they would have got the message. \nThe meeting itself was off the record to the media. \nWashington has already issued several warnings, most recently on August 8, of terrorist threats in Indonesia, and said places where Americans and other foreigners gather or reside are potential targets. \nWhile all but one of those who died in the Aug. 5 Marriott attack were Indonesians, the hotel was viewed as a Western symbol, and had been used by the US embassy for various events. \nAustralia issued a warning yesterday for its citizens to avoid all international hotels in Jakarta after new intelligence found the capital could be under threat of further attacks.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very